Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE: DBD)

Market Cap	4.43T
Revenue (ttm)	1.69T
Net Income (ttm)	235.82B
Shares Out	93.55M
EPS (ttm)	2,520.67
PE Ratio	18.76
Forward PE	16.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	47,000
Previous Close	47,000
Day's Range	46,450 - 47,500
52-Week Range	39,000 - 51,400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About DBD

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; antifungal and antiviral drugs; hemodialysis solutions; hepatobiliary; analgesic and antipyretic drugs; anti-inflammatory analgesic drugs; drugs for muscle, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs for brain circulation improvement; vitamins and minerals; endocrine hormones; ...

• Industry: Pharmaceutical Preparations
• CEO: Huong Thi Pham
• Employees: 1,303
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBD

Financial Performance

In 2023, DBD's revenue was 1.65 trillion, an increase of 6.24% compared to the previous year's 1.55 trillion. Earnings were 231.39 billion, an increase of 10.47%.